Researchers around the world agree that:
“Improvements in child health through research will be made at an increasingly accelerated pace during the post-genomic era. Advances made possible through genomics, proteomics, and the application of nanosystem technology will enhance our ability to prevent, modify, or cure numerous childhood disorders.” (Dr. Robert Feigin, Prospects for the Future of Child Health Through Research, JAPA, Sept. 2005)
“The most promising effects of gene therapy, other genomic and proteomic techniques, and stem cell transplantation, to date, have been in the diagnosis and treatment of cancer. Future clinical research efforts will be directed at addressing those clinical situations, for example, brain tumors.” We believe JPA, a non-malignant cancer should be one of them. (Dr. Robert Feigin, Prospects for the Future of Child Health Through Research, JAPA, Sept. 2005)
“PLGAs are understudied, and an extremely challenging and often devastating form of childhood brain tumor. More research is desperately needed to develop new means of treatment and we are committed to accelerating research using promising new approaches for these tumors. (Dr. Roger Packer,Senior Medical Advisor for the Childhood Brain Tumor Foundation, Executive Director and Chairman of the Department of Neurology at Children’s National Medical Center in Washington DC, and a Founder of the International Society for Pediatric Neuro Oncology)
The PLGA Foundation encourages scientists worldwide to provide an Executive Summary and a link to any PLGA specific research which has been completed in the past 3 years; the executive summaries and links to complete copies of the published results will be added here. Please contact us at firstname.lastname@example.org for questions or clarifications.